Bortezomib Intravenous and Ziv-aflibercept Intravenous

• Generic Name: bortezomib
• Dosage Forms: n.a.
• Other Brand Names: Velcade

Bortezomib injection is used to treat multiple myeloma (blood plasma cell cancer) in patients with or without a prior history of treatment, and mantle cell lymphoma.

Bortezomib is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal body cells may also be affected by bortezomib, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, such as a skin rash, may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.

Bortezomib is to be given only by or under the supervision of your doctor.

• Generic Name: ziv-aflibercept
• Dosage Forms: n.a.
• Other Brand Names: Zaltrap

Ziv-aflibercept injection is given together with other medicines to treat advanced cancer of the colon or rectum. It is used in patients who have already been treated with other cancer medicines that did not work well. Ziv-aflibercept works by changing the amount of blood that gets to the tumor.

Ziv-aflibercept is to be administered only by or under the direct supervision of your doctor.